Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for PharmChem Inc. (PCHM : OTC)

• Company Description    PharmChem is an independent laboratory providing integrated drug testing services on a national basis to corporate and governmental clients seeking to detect and deter the use of illegal drugs. PharmChem operates a certified forensic drug-testing laboratory in Haltom City, Texas. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $3.90 Daily Weekly Monthly 20 Day Moving Average: 1,755 shares Shares Outstanding: 4.65 (millions) Market Capitalization: $18.13 (millions) Beta: 0.77 52 Week High: $3.95 52 Week Low: $2.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.90% -1.75% 12 Week 31.31% 10.82% Year To Date 27.45% 19.75%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4600 BEACH STREET - HALTOM CITY,TX 76137 USA ph: 817-605-5300 fax: 817-605-6400 None http://www.pharmchem.com

• General Corporate Information    Officers Richard D. Irwin - Chairman Joseph W. Halligan - President; Chief Executive Officer and Director David A. Lattanzio - Chief Financial Officer; Vice President; Finance a Donald R. Stroben - Director Stephen I. Schorr - Director Peer Information PharmChem Inc. (CMTI) PharmChem Inc. (CMWLQ) PharmChem Inc. (AHG.) PharmChem Inc. (ROIX) PharmChem Inc. (M.DCE) PharmChem Inc. (DHSM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-OUTP/HM CRE Sector: Medical CUSIP: 717133102 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/05/25 Share - Related Items Shares Outstanding: 4.65 Most Recent Split Date: (:1) Beta: 0.77 Market Capitalization: $18.13 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 12.19 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 2.91 EPS Growth vs. Year Ago Period: 100.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 9.27% vs. Previous Quarter: 3.74% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - 24.02 12/31/24 - 22.67 Net Margin 06/30/25 - - 03/31/25 - 24.02 12/31/24 - 22.67 Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©